Oxolife has been featured in Femtech Insider a leading platform spotlighting innovation in women’s health.
We truly value the visibility Femtech Insider brings to our mission and deeply appreciate their commitment to amplifying the voices and efforts of femtech pioneers.
At Oxolife, we are moving forward with more energy and commitment than ever, driven by a clear purpose: to deliver innovative solutions that close therapeutic gaps and address the unmet needs in women’s reproductive health.
Our compound OXO-001 represents a first-in-class approach designed to improve embryo implantation and address Polycystic Ovary Syndrome (PCOS) in a holistic way — with the goal of transforming outcomes for women worldwide.
We remain committed to advancing science that makes a real difference.
More info: https://lnkd.in/gsHJjT2R